The first is misleading ads . Vioxx and a similar drug from Pfizer Inc., Celebrex, have been touted as "super-aspirins" in numerous TV commercials that have downplayed their known cardiovascular risks . Such commercials show how far the Food and Drug Administration has slipped in enforcing its own rules . When the agency determines a drug company has made a misleading ad, it first issues a warning letter, then imposes a fine if the ad is not pulled . But the number of warning letters has dropped precipitously since the Bush administration took power